secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vicarious Surgical Inc. (RBOT)
CIK:        0001812173
Form:       8-K
Filed at:   2023-01-23T23:59:59+00:00
Accession:  0001213900-23-004450
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vicarious Surgical appoints Victoria Carr-Brendel to board; Phil Liang resigns
------------------------------------------------------------------------------

- Victoria Carr-Brendel, Ph.D., appointed to board effective Jan 23, 2023; deemed independent under NYSE rules.
- Carr-Brendel is Group VP of Cochlear Implants at Sonova Group and President of Advanced Bionics.
- She previously served as CEO of JenaValve and held roles at Boston Scientific (NYSE:BSX).
- Philip Liang resigned from board effective Jan 23, 2023; not due to any disagreement with the company.
- Standard nonemployee director compensation and indemnification agreement apply to Carr-Brendel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812173/000121390023004450/0001213900-23-004450-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812173/000121390023004450/ea172024-8k_vicarious.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-004450

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer